Pulling SEC filings + quote and writing the call…
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $298M | $344M | $446M | $459M | $434M | $488M | $488M | $504M | $501M | $533M |
| Revenue growth | — | 15.6% | 29.3% | 2.9% | -5.3% | 12.4% | 0.1% | 3.2% | -0.6% | 6.4% |
| Gross profit | $167M | $194M | $239M | $235M | $218M | $223M | $215M | $222M | $223M | $237M |
| Gross margin | 56.0% | 56.3% | 53.6% | 51.3% | 50.1% | 45.6% | 44.1% | 44.1% | 44.6% | 44.5% |
| Operating income | $61.8M | $72.2M | $88.9M | $79.9M | $59.8M | $40.3M | -$98.0M | $28.2M | $19.9M | $25.1M |
| Operating margin | 20.7% | 21.0% | 20.0% | 17.4% | 13.8% | 8.3% | -20.1% | 5.6% | 4.0% | 4.7% |
| Net income | $42.7M | $51.8M | $76.6M | $63.7M | $50.9M | $33.4M | -$103M | $17.2M | $16.6M | $21.2M |
| Net margin | 14.3% | 15.0% | 17.2% | 13.9% | 11.7% | 6.8% | -21.2% | 3.4% | 3.3% | 4.0% |
| EPS (diluted) | $1.61 | $1.93 | $2.81 | $2.35 | $1.89 | $1.21 | -$3.77 | $0.66 | $0.66 | $0.88 |
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $77.5M | $81.7M | $123M | $116M | $107M | $55.2M | $62.1M | $73.3M | $77.8M | $74.5M |
| Capital expenditures | $33.6M | $32.6M | $87.1M | $62.2M | $47.0M | $34.2M | $21.7M | $28.1M | $9.17M | $14.8M |
| Free cash flow | $43.9M | $49.1M | $35.8M | $53.8M | $60.0M | $21.0M | $40.4M | $45.2M | $68.7M | $59.7M |
| Share buybacks | — | $4.41M | $12.2M | $33.5M | $14.7M | $23.3M | $29.7M | $44.0M | $60.3M | $43.0M |
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $68.8M | $36.7M | $85.0M | $125M | $128M | $65.9M | $56.6M | $83.8M | $89.1M | $111M |
| Total assets | $414M | $519M | $619M | $674M | $744M | $929M | $802M | $772M | $744M | $763M |
| Total liabilities | $34.4M | $57.5M | $77.5M | $87.9M | $99.8M | $100M | $105M | $77.1M | $73.4M | $89.5M |
| Shareholders' equity | $380M | $461M | $541M | $586M | $644M | $828M | $698M | $695M | $670M | $674M |
| Retained earnings | $177M | $225M | $291M | $325M | $363M | $377M | $258M | $256M | $244M | $241M |
| Shares (wtd avg diluted) | 26.6M | 26.8M | 27.3M | 27.0M | 26.9M | 27.7M | 27.4M | 26.2M | 25.2M | 24.2M |
Every figure is extracted from Proto Labs Inc’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.